195 related articles for article (PubMed ID: 21394012)
1. High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience.
Ng KK; Poon RT; Chan SC; Chok KS; Cheung TT; Tung H; Chu F; Tso WK; Yu WC; Lo CM; Fan ST
Ann Surg; 2011 May; 253(5):981-7. PubMed ID: 21394012
[TBL] [Abstract][Full Text] [Related]
2. Follow-up of high-intensity focused ultrasound treatment for patients with hepatocellular carcinoma.
Xu G; Luo G; He L; Li J; Shan H; Zhang R; Li Y; Gao X; Lin S; Wang G
Ultrasound Med Biol; 2011 Dec; 37(12):1993-9. PubMed ID: 22036638
[TBL] [Abstract][Full Text] [Related]
3. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
4. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience.
Fan ST; Mau Lo C; Poon RT; Yeung C; Leung Liu C; Yuen WK; Ming Lam C; Ng KK; Ching Chan S
Ann Surg; 2011 Apr; 253(4):745-58. PubMed ID: 21475015
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma.
Li C; Zhang W; Zhang R; Zhang L; Wu P; Zhang F
Eur J Cancer; 2010 Sep; 46(13):2513-21. PubMed ID: 20663659
[TBL] [Abstract][Full Text] [Related]
6. High intensity focused ultrasound (HIFU) therapy for local treatment of hepatocellular carcinoma: role of partial rib resection.
Zhu H; Zhou K; Zhang L; Jin C; Peng S; Yang W; Li K; Su H; Chen W; Bai J; Wu F; Wang Z
Eur J Radiol; 2009 Oct; 72(1):160-6. PubMed ID: 18707834
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma.
Sasaki A; Kai S; Iwashita Y; Hirano S; Ohta M; Kitano S
Cancer; 2005 Jan; 103(2):299-306. PubMed ID: 15578688
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous radiofrequency ablation for the treatment of hepatocellular carcinoma in the caudate lobe.
Peng ZW; Liang HH; Chen MS; Zhang YJ; Li JQ; Zhang YQ; Lau WY
Eur J Surg Oncol; 2008 Feb; 34(2):166-72. PubMed ID: 17851020
[TBL] [Abstract][Full Text] [Related]
9. Factors in successful radiofrequency ablation therapy for malignant liver tumors.
Sakakima Y; Inoue S; Takeda S; Kaneko T; Nakao A
Hepatogastroenterology; 2004; 51(60):1761-5. PubMed ID: 15532821
[TBL] [Abstract][Full Text] [Related]
10. Prognostic importance of the gross classification of hepatocellular carcinoma in living donor-related liver transplantation.
Shirabe K; Aishima S; Taketomi A; Soejima Y; Uchiyama H; Kayashima H; Ninomiya M; Mano Y; Maehara Y
Br J Surg; 2011 Feb; 98(2):261-7. PubMed ID: 21072849
[TBL] [Abstract][Full Text] [Related]
11. Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma.
Li YY; Sha WH; Zhou YJ; Nie YQ
J Gastroenterol Hepatol; 2007 Dec; 22(12):2148-54. PubMed ID: 18031373
[TBL] [Abstract][Full Text] [Related]
12. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
[TBL] [Abstract][Full Text] [Related]
13. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
14. Particle embolization of recurrent hepatocellular carcinoma after hepatectomy.
Covey AM; Maluccio MA; Schubert J; BenPorat L; Brody LA; Sofocleous CT; Getrajdman GI; Fong Y; Brown KT
Cancer; 2006 May; 106(10):2181-9. PubMed ID: 16596622
[TBL] [Abstract][Full Text] [Related]
15. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN
Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma.
Dhanasekaran R; Khanna V; Kooby DA; Spivey JR; Parekh S; Knechtle SJ; Carew JD; Kauh JS; Kim HS
J Vasc Interv Radiol; 2010 Aug; 21(8):1197-204; quiz 204. PubMed ID: 20656222
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival and prognostic factors after pulmonary metastasectomy in hepatocellular carcinoma.
Yoon YS; Kim HK; Kim J; Choi YS; Shim YM; Paik SW; Kim K
Ann Surg Oncol; 2010 Oct; 17(10):2795-801. PubMed ID: 20517683
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization for hepatocellular carcinoma with portal vein invasion: a helpful palliative approach.
Schumacher G; Gebauer B
J Gastroenterol Hepatol; 2009 Aug; 24(8):1317-9. PubMed ID: 19702898
[No Abstract] [Full Text] [Related]
19. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.
Cheung TT; Ng KK; Poon RT; Fan ST
J Hepatobiliary Pancreat Surg; 2009; 16(5):655-60. PubMed ID: 19370304
[TBL] [Abstract][Full Text] [Related]
20. Salvage surgery for uncontrollable hepatocellular carcinoma treated with repeated non-surgical therapies.
Ochiai T; Sonoyama T; Ikoma H; Kuriu Y; Nakanishi M; Kubota T; Kikuchi S; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Kokuba Y; Otsuji E
Hepatogastroenterology; 2010; 57(101):858-64. PubMed ID: 21033242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
